IDYA
IDEAYA Biosciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website ideayabio.com
- Employees(FY) 122
- ISIN US45166A1025
Performance
-0.34%
1W
-1.63%
1M
-14.07%
3M
+35.27%
6M
+13.83%
YTD
+91.4%
1Y
Profile
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase II clinical trial for patients with solid tumors having methylthioadenosine phosphorylase gene deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester todevelop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase II/III study in metastatic uveal melanoma, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Investment Analysis Report: IDYA
Overview
In this investment analysis report, we will delve into a comprehensive analysis of IDYA, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ...
Technical Analysis of IDYA 2024-05-10
Overview:
In analyzing the technical indicators for IDYA over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potential inv...
Recent News & Updates
- 2024-05-16 17:57
- 2024-05-08 08:47
- 2024-05-08 07:41
- 2024-05-07 10:23
IDEAYA Biosciences Shares Fall After Q1 Loss(MT Newswires)
- 2024-05-07 07:35
- 2024-05-07 06:00
- 2024-05-07 01:54
- 2024-05-06 18:00
- 2024-05-01 06:00
- 2024-04-30 18:00
- 2024-04-26 06:00
- 2024-04-25 18:00
- 2024-04-24 10:05
- 2024-04-23 22:05
- 2024-04-22 06:00
- 2024-04-21 18:00
- 2024-04-05 06:00
- 2024-04-04 18:00
- 2024-04-01 06:00
- 2024-03-31 18:00
- 2024-03-27 09:25
- 2024-03-12 06:00
- 2024-03-11 18:00
- 2024-03-04 06:00
- 2024-03-03 17:00
- 2024-02-23 05:54
- 2024-02-20 06:00
- 2024-02-19 17:36
- 2024-02-19 17:00
- 2024-02-13 05:37
IDEAYA Biosciences Inc CEO Yujiro Hata Sells 99,372 Shares(GuruFocus.com)
Page 1 of 5
previousnext